Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Feb 21, 2018)
  • 8-K (Feb 8, 2018)
  • 8-K (Nov 13, 2017)
  • 8-K (Oct 30, 2017)
  • 8-K (Oct 24, 2017)
  • 8-K (Sep 7, 2017)

 
Other

MediciNova 8-K 2006

Documents found in this filing:

  1. 8-K
  2. Ex-99.1
  3. Graphic
  4. Graphic
Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 9, 2006

 


 

MEDICINOVA, INC.

(Exact name of registrant as specified in its charter)

 


 

Delaware   000-51133   33-0927979
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

4350 La Jolla Village Drive, Suite 950

San Diego, CA 92122

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (858) 373-1500

 

Not Applicable

(Former name or former address, if changed since last report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

 

On January 9, 2006, the Board of Directors of the Registrant appointed Jeff Himawan, Ph.D., to the Board of Directors of the Registrant. Dr. Himawan brings to the Registrant a broad range of expertise developed by more than 15 years of experience as a scientist, entrepreneur and venture capitalist. Dr. Himawan has led investments in, and currently also serves on the boards of, Symphogen, Iomai and Light Sciences Oncology. Dr. Himawan joined Essex Woodlands Health Ventures as a Managing Director in 2001. One of the investment funds that Essex Woodlands Health Ventures manages is currently a significant holder of the Registrant’s common stock. Prior to joining Essex Woodlands Health Ventures, Dr. Himawan was Managing Director and Co-founder of Seed-One Ventures, where he managed the early corporate development of Elusys Therapeutics and Sensatex. Prior to Seed-One, he was a scientist in academic and industrial settings. Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University.

 

Item 8.01 Other Events.

 

On January 12, 2006, the Registrant announced the appointment of Jeff Himawan to its board of directors.

 

Attached as Exhibit 99.1 hereto and incorporated herein by reference in its entirety is the press release issued by the Company on January 12, 2006.

 

Item 9.01 Financial Statements and Exhibits.

 

(c) Exhibits.

 

Exhibit

  

Description


99.1    Press Release issued January 12, 2006.

 

2


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: January 13, 2006.

 

MEDICINOVA, INC.

By:

 

/s/ Shintaro Asako

   

Shintaro Asako

   

Vice President, Accounting and Administration

 

3


EXHIBIT INDEX

 

Exhibit No.

  

Description


99.1    Press Release issued January 12, 2006.

 

4

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki